These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34868205)

  • 41. Novel long non-coding RNA LINC02323 promotes epithelial-mesenchymal transition and metastasis via sponging miR-1343-3p in lung adenocarcinoma.
    Zhang X; Du L; Han J; Li X; Wang H; Zheng G; Wang Y; Yang Y; Hu Y; Wang C
    Thorac Cancer; 2020 Sep; 11(9):2506-2516. PubMed ID: 32643848
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of the prognostic and therapeutic values of cyclin E1 (
    Ullah MA; Farzana M; Islam MS; Moni R; Zohora US; Rahman MS
    Heliyon; 2022 Sep; 8(9):e10367. PubMed ID: 36091953
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High expression of SLC6A10P contributes to poor prognosis in lung adenocarcinoma.
    Yuan K; Gao ZJ; Yuan WD; Yuan JQ; Wang Y
    Int J Clin Exp Pathol; 2018; 11(2):720-726. PubMed ID: 31938158
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comprehensive Profiling of Genomic and Transcriptomic Differences between Risk Groups of Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
    Zengin T; Önal-Süzek T
    J Pers Med; 2021 Feb; 11(2):. PubMed ID: 33672117
    [TBL] [Abstract][Full Text] [Related]  

  • 45. LncRNAs are altered in lung squamous cell carcinoma and lung adenocarcinoma.
    Liu B; Chen Y; Yang J
    Oncotarget; 2017 Apr; 8(15):24275-24291. PubMed ID: 27903974
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Annexin A13 predicts poor prognosis for lung adenocarcinoma patients and accelerates the proliferation and migration of lung adenocarcinoma cells by modulating epithelial-mesenchymal transition.
    Xue GL; Zhang C; Zheng GL; Zhang LJ; Bi JW
    Fundam Clin Pharmacol; 2020 Dec; 34(6):687-696. PubMed ID: 32145097
    [TBL] [Abstract][Full Text] [Related]  

  • 47.
    Wei S; Shao J; Wang J; Zhao T; Liu J; Shen X; Wang Y; Chen H; Wang G
    J Thorac Dis; 2022 Jul; 14(7):2652-2664. PubMed ID: 35928621
    [TBL] [Abstract][Full Text] [Related]  

  • 48. m
    Wu H; Xu H; Huang S; Tang Y; Tang J; Zhou H; Xie L; Qiao G
    Front Oncol; 2022; 12():989817. PubMed ID: 36249006
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ERRα is an aggressive factor in lung adenocarcinoma indicating poor prognostic outcomes.
    Li P; Wang J; Wu D; Ren X; Wu W; Zuo R; Zeng Q; Wang B; He X; Yuan J; Xie N
    Cancer Manag Res; 2019; 11():8111-8123. PubMed ID: 31564971
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Overexpression of FAM83A Is Associated with Poor Prognosis of Lung Adenocarcinoma.
    Liu X; Fu M; Xia D; Ji Z; Hu N; Leng Z; Xie W; Fang Y; Zhang J
    J Oncol; 2022; 2022():8767333. PubMed ID: 36245969
    [TBL] [Abstract][Full Text] [Related]  

  • 51. LDH-A promotes malignant behavior via activation of epithelial-to-mesenchymal transition in lung adenocarcinoma.
    Hou XM; Yuan SQ; Zhao D; Liu XJ; Wu XA
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30509961
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential
    Lin S; Tian C; Li J; Liu B; Ma T; Chen K; Gong W; Wang JM; Huang J
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33786615
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sp1-induced upregulation of the long noncoding RNA TINCR inhibits cell migration and invasion by regulating miR-107/miR-1286 in lung adenocarcinoma.
    Gao YW; Ma F; Xie YC; Ding MG; Luo LH; Jiang S; Rao L; Liu XL
    Am J Transl Res; 2019; 11(8):4761-4775. PubMed ID: 31497197
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High expression of CD73 contributes to poor prognosis of clear-cell renal cell carcinoma by promoting cell proliferation and migration.
    Zhou Y; Jiang D; Chu X; Yan M; Qi H; Wu X; Tang Y; Dai Y
    Transl Cancer Res; 2022 Oct; 11(10):3634-3644. PubMed ID: 36388013
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High
    Xie L; Dang Y; Guo J; Sun X; Xie T; Zhang L; Yan Z; Amin H; Guo X
    Genes (Basel); 2019 Jan; 10(1):. PubMed ID: 30634629
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of a Three-Gene Signature Based on Epithelial-Mesenchymal Transition of Lung Adenocarcinoma Through Construction and Validation of a Risk-Prediction Model.
    Shi J; Wang Z; Guo J; Chen Y; Tong C; Tong J; Hu W; Li C; Li X
    Front Oncol; 2021; 11():726834. PubMed ID: 34745947
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Overexpression of LRRC59 Is Associated with Poor Prognosis and Promotes Cell Proliferation and Invasion in Lung Adenocarcinoma.
    Li D; Xing Y; Tian T; Guo Y; Qian J
    Onco Targets Ther; 2020; 13():6453-6463. PubMed ID: 32753886
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Independent prognostic implications of
    Ma C; Luo H; Cao J; Gao C; Fa X; Wang G
    J Cancer; 2020; 11(23):7009-7022. PubMed ID: 33123291
    [No Abstract]   [Full Text] [Related]  

  • 59. Transcriptome analysis of distinct long non-coding RNA transcriptional fingerprints in lung adenocarcinoma and squamous cell carcinoma.
    Wei Y; Zhang X
    Tumour Biol; 2016 Oct; ():. PubMed ID: 27797003
    [TBL] [Abstract][Full Text] [Related]  

  • 60. TOX correlates with prognosis, immune infiltration, and T cells exhaustion in lung adenocarcinoma.
    Guo L; Li X; Liu R; Chen Y; Ren C; Du S
    Cancer Med; 2020 Sep; 9(18):6694-6709. PubMed ID: 32700817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.